Home › Cervical Cancer › NCT06850402

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

Who can join

Ages 25 to 49 · Women

Inclusion Criteria:

1. Women aged 25 - 49 years
2. women undergoing cervical biopsy and/or LEEP
3. Women who are not pregnant and with a negative pregnancy test (within 3 days of enrollment)
4. Willing and capable of providing informed consent

Exclusion Criteria:

1. Women under 25 or over 49 years of age
2. Women not undergoing cervical biopsy or LEEP
3. Women who are pregnant

About the study

All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.

What is being tested

• DeepDOF Images (device)

Sponsor: M.D. Anderson Cancer Center · Participants: 400 · Started: Sep 22, 2025

Contact the study team

• Kathleen M Schmeler, MD · Phone: (713) 854-9150

Official record on ClinicalTrials.gov — NCT06850402

Locations in the U.S.

Conditions

• Cervical Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.